miR-7 is a common regulator of the PI3K/Akt and Raf/MEK/ERK pathways, both of which are launched by EGFR, and is a potential glioblastoma suppressor that acts by targeting multiple oncogenes related to the downstream pathway of EGFR. The gene discussed is AKT1; the disease is glioblastoma.